Skip to main content
logo
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,618.00
+42.00 (2.66%)
Nov 2, 2026, 3:30 PM KST

NeoImmuneTech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
159,968405,851556,1291,001,0331,974,0795,091,787
Market Cap Growth
-44.11%-27.02%-44.44%-49.29%-61.23%-
Enterprise Value
123,974345,927519,849923,7121,838,8434,930,203
Last Close Price
1576.004105.004672.018409.6216590.8442982.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
88.534280.053263.98---
PB Ratio
2.766.8513.3513.3716.4931.42
P/TBV Ratio
4.318.7515.8014.5717.4532.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
68.083648.103051.04---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.200.180.260.050.040.04
Net Debt / Equity Ratio
-0.64-0.85-0.57-0.87-0.94-0.92
Net Debt / EBITDA Ratio
1.972.200.641.242.032.97
Net Debt / FCF Ratio
1.522.000.591.292.504.06
Asset Turnover
0.030.000.00---
Quick Ratio
2.682.941.675.367.147.57
Current Ratio
2.833.081.895.617.208.17
Return on Equity (ROE)
-61.03%-63.04%-70.17%-54.90%-42.88%-42.62%
Return on Assets (ROA)
-21.14%-21.48%-32.84%-30.30%-22.25%-22.95%
Return on Capital Employed (ROCE)
-36.40%-41.30%-91.80%-71.90%-47.10%-31.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.13%-7.83%-7.35%-5.33%-3.06%-1.03%
FCF Yield
-15.22%-6.19%-7.30%-5.05%-2.27%-0.72%
Buyback Yield / Dilution
-110.94%-19.34%0.24%-0.08%-3.68%-15.27%